Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review Molly LinSujin ParkLuke Y.C. Chen Review Article 12 May 2017 Pages: 1241 - 1251
Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients? Giovanni Di MinnoDavid NavarroAndreas Tiede Review Article Open access 18 June 2017 Pages: 1253 - 1270
Vitamin D and plasma cell dyscrasias: reviewing the significance Nicholas Burwick Review Article 13 May 2017 Pages: 1271 - 1277
Central nervous system involvement in adults with haemophagocytic lymphohistiocytosis: a single-center study Guilan CaiYini WangZhao Wang Original Article 07 June 2017 Pages: 1279 - 1285
Influence of TNF and IL6 gene polymorphisms on the severity of cytopenias in Argentine patients with myelodysplastic syndromes Yesica BestachVirginia Palau NagoreCarolina Belli Original Article 10 June 2017 Pages: 1287 - 1295
Thromboses and hemorrhages are common in MPN patients with high JAK2V617F allele burden Irene BertozziGiulia BogoniMaria Luigia Randi Original Article 06 June 2017 Pages: 1297 - 1302
Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios Giuseppe SaglioPhilipp le CoutreNeil P. Shah Original Article Open access 22 May 2017 Pages: 1303 - 1313
Rethinking the usefulness of bone marrow biopsy on treatment decision in CLL patients at diagnosis Rafet ErenMehmet Hilmi DoğuElif Suyanı Original Article 24 April 2017 Pages: 1315 - 1321
Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO) A. García-NoblejasJ. Cannata-OrtizR. Arranz Original Article 24 May 2017 Pages: 1323 - 1330
Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution Yuhua HuangHuilan RaoYujing Zhang Original Article Open access 27 May 2017 Pages: 1331 - 1342
Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience Mao LiYongqian JiaCaigang Xu Original Article Open access 16 June 2017 Pages: 1343 - 1351
Reduced-intensity allogeneic hematopoietic stem cell transplantation combined with imatinib has comparable event-free survival and overall survival to long-term imatinib treatment in young patients with chronic myeloid leukemia Yanmin ZhaoJiasheng WangHe Huang Original Article 17 June 2017 Pages: 1353 - 1360
Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation Michael HeuserRazif GabdoullineFelicitas Thol Original Article 13 June 2017 Pages: 1361 - 1372
Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease Volker WiebkingSebastian HütkerMichael H. Albert Original Article 01 June 2017 Pages: 1373 - 1377
Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT) Annekathrin HilkenClaudia LangebrakeNicolaus Kröger Original Article 06 June 2017 Pages: 1379 - 1388
Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes Qian LiChangying LuoJing Chen Original Article 16 June 2017 Pages: 1389 - 1397
Co-mutated CALR and MPL driver genes in a patient with myeloproliferative neoplasm Mónica BernalPilar JiménezManuel Jurado Letter to the Editor 17 May 2017 Pages: 1399 - 1401
Variant of classical high grade PTLD: post-transplant EBV-negative T cell lymphoblastic leukaemia after solid organ transplantation Kristin TeikenHans KreipeKais Hussein Letter to the Editor 14 June 2017 Pages: 1403 - 1405
Anti-CD138 chimeric antigen receptor-modified T cell therapy for multiple myeloma with extensive extramedullary involvement Chen TianHongliang YangYizhuo Zhang Letter to the Editor 02 June 2017 Pages: 1407 - 1410
Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation Satoko OkaKazuo OnoMasaharu Nohgawa Letter to the editor Open access 02 June 2017 Pages: 1411 - 1413
Sweet syndrome secondary to myelodysplastic syndrome mimicking necrotizing fasciitis Kai ShenBing XiangTing Liu Letter to the editor 07 June 2017 Pages: 1415 - 1416
Co-occurrence of type I CALR and two MPL mutations in patient with primary myelofibrosis Hammad TashkandiErika M. MooreNavid Sadri Letter to the Editor 13 May 2017 Pages: 1417 - 1418
Erratum to: Good adherence to imatinib therapy among patients with chronic myeloid leukemia—a single-center observational study Sofia JönssonBob OlssonHans Wadenvik Erratum 09 June 2017 Pages: 1419 - 1419